Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study - Concepedia

Concepedia

Publication | Open Access

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

DOI Full Paper Access

12

Citations

23

References

2025

Year

Cristina Marchetti, Anna Fagotti, Robert Fruscio, Chiara Cassani, Lorena Incorvaia, M T Perri, Carolina Maria Sassu, Cristina Angela Camnasio, Emilia Giudice, Angelo Minucci,

References

	Year	Citations

Page 1